← Back to Search

Hip Precautions for Hip Arthritis

N/A
Recruiting
Led By Brett Levine, MD, MS
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Index diagnosis of noninflammatory arthritis
Be older than 18 years old
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up6 weeks after surgery
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will help determine if hip precautions after surgery help prevent hip dislocation and improve patient satisfaction.

Eligible Conditions
  • Osteoarthritis

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Select...
You have been diagnosed with a type of arthritis that is not caused by inflammation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dislocation
Secondary outcome measures
Activities of Daily Living
Other outcome measures
Use of Assistive Devices After Surgery

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: No Hip PrecautionsExperimental Treatment1 Intervention
Patients will not be prescribed hip precautions in the first 6 weeks after surgery. The hip precautions that will no longer be prescribed are: no hip flexion past 90º, no crossing the legs, and no twisting at the waist.
Group II: Hip PrecautionsActive Control1 Intervention
Patients will receive the following hip precautions: no hip flexion past 90º, no crossing the legs, and no twisting at the waist for the first six weeks after surgery.

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
411 Previous Clinical Trials
160,011 Total Patients Enrolled
25 Trials studying Osteoarthritis
2,238 Patients Enrolled for Osteoarthritis
Brett Levine, MD, MS4.8237 ReviewsPrincipal Investigator - Assistant Professor
Rush University Medical Center
5Patient Review
I feel so lucky to have found Dr Levine and his team. They were able to help me through my surgery and recovery with such ease and care. I was originally drawn to him because he came highly recommended as a physician who worked with challenging cases, but what really won me over was his team's respect for my concerns and their dedication to keeping me well informed. I also loved the daily educational text support — it gave me a step-by-step guide of valuable information that was crucial for my successful recovery. With Dr Levine and his team, I know I'm in good hands for my next surgery.

Media Library

Hip Precautions Clinical Trial Eligibility Overview. Trial Name: NCT02686528 — N/A
Osteoarthritis Research Study Groups: No Hip Precautions, Hip Precautions
Osteoarthritis Clinical Trial 2023: Hip Precautions Highlights & Side Effects. Trial Name: NCT02686528 — N/A
Hip Precautions 2023 Treatment Timeline for Medical Study. Trial Name: NCT02686528 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit of participants involved in this trial?

"Affirmative, the information on clinicaltrials.gov attests that this medical investigation is actively recruiting volunteers. This study was initially uploaded to the website on January 1st 2016 and has been recently amended on October 25th 2022. Currently 1000 participants need to be enrolled from a single trial site."

Answered by AI

Does this research project still have vacancies for participants?

"According to the particulars on clinicaltrials.gov, this scientific study is in a recruitment phase and requires new participants. The trial was initially publicized on January 1st 2016 with its most recent update occurring on October 25th 2022."

Answered by AI
~120 spots leftby Jan 2025